Literature DB >> 25848471

Magnetic resonance imaging of the cirrhotic liver: An update.

Agnes Watanabe1, Miguel Ramalho1, Mamdoh AlObaidy1, Hye Jin Kim1, Fernanda G Velloni1, Richard C Semelka1.   

Abstract

Noninvasive imaging has become the standard for hepatocellular carcinoma (HCC) diagnosis in cirrhotic livers. In this review paper, we go over the basics of MR imaging in cirrhotic livers and describe the imaging appearance of a spectrum of hepatic nodules marking the progression from regenerative nodules to low- and high-grade dysplastic nodules, and ultimately to HCCs. We detail and illustrate the typical imaging appearances of different types of HCC including focal, multi-focal, massive, diffuse/infiltrative, and intra-hepatic metastases; with emphasis on the diagnostic value of MR in imaging these lesions. We also shed some light on liver imaging reporting and data system, and the role of different magnetic resonance imaging (MRI) contrast agents and future MRI techniques including the use of advanced MR pulse sequences and utilization of hepatocyte-specific MRI contrast agents, and how they might contribute to improving the diagnostic performance of MRI in early stage HCC diagnosis.

Entities:  

Keywords:  Dysplastic nodules; Hepatic nodules; Hepatocellular carcinoma; Liver imaging reporting and data system; Magnetic resonance imaging; Regenerative nodules

Year:  2015        PMID: 25848471      PMCID: PMC4381170          DOI: 10.4254/wjh.v7.i3.468

Source DB:  PubMed          Journal:  World J Hepatol


  94 in total

1.  Development of hepatocellular carcinomas in patients with absence of tumors on a prior ultrasound examination.

Authors:  Kyung Ah Kim; Myeong-Jin Kim; Jin-Young Choi; Yong Eun Chung
Journal:  Eur J Radiol       Date:  2011-04-22       Impact factor: 3.528

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

4.  Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.

Authors:  David J S Becker-Weidman; Bobby Kalb; Puneet Sharma; Hiroumi D Kitajima; Christina R Lurie; Zhengjia Chen; James R Spivey; Stuart J Knechtle; Steven I Hanish; N Volkan Adsay; Alton B Farris; Diego R Martin
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

5.  Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Yan Shan; Yuan Ji; Cai-Zhong Chen
Journal:  J Comput Assist Tomogr       Date:  2010-07       Impact factor: 1.826

Review 6.  Imaging of HCC.

Authors:  Carmen Ayuso; Jordi Rimola; Angeles García-Criado
Journal:  Abdom Imaging       Date:  2012-04

7.  Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.

Authors:  Satoshi Goshima; Masayuki Kanematsu; Masayuki Matsuo; Hiroshi Kondo; Hiroki Kato; Ryujiro Yokoyama; Hiroaki Hoshi; Noriyuki Moriyama
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

8.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Jiang Lin; Yuan Ji
Journal:  J Magn Reson Imaging       Date:  2009-02       Impact factor: 4.813

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  9 in total

1.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

2.  Deep learning supports the differentiation of alcoholic and other-than-alcoholic cirrhosis based on MRI.

Authors:  Julian A Luetkens; Sebastian Nowak; Alois Martin Sprinkart; Anton Faron; Ulrike Attenberger; Narine Mesropyan; Wolfgang Block; Michael Praktiknjo; Johannes Chang; Christian Bauckhage; Rafet Sifa
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

3.  Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease.

Authors:  Juan S Calle-Toro; Suraj D Serai; Erum A Hartung; David J Goldberg; Bradley D Bolster; Kassa Darge; Sudha A Anupindi
Journal:  Abdom Radiol (NY)       Date:  2019-03

Review 4.  Focal liver lesions: Practical magnetic resonance imaging approach.

Authors:  António P Matos; Fernanda Velloni; Miguel Ramalho; Mamdoh AlObaidy; Aruna Rajapaksha; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-08-08

Review 5.  Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.

Authors:  Miguel Ramalho; António P Matos; Mamdoh AlObaidy; Fernanda Velloni; Ersan Altun; Richard C Semelka
Journal:  Radiol Bras       Date:  2017 Jan-Feb

Review 6.  Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2.

Authors:  Miguel Ramalho; António P Matos; Mamdoh AlObaidy; Fernanda Velloni; Ersan Altun; Richard C Semelka
Journal:  Radiol Bras       Date:  2017 Mar-Apr

Review 7.  Magnetic resonance imaging ancillary features used in Liver Imaging Reporting and Data System: An illustrative review.

Authors:  David Campos-Correia; João Cruz; António P Matos; Filipa Figueiredo; Miguel Ramalho
Journal:  World J Radiol       Date:  2018-02-28

8.  Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.

Authors:  Xianfeng Zhang; Xianjun Zhang; Xinguo Li; Hongbing Bao; Guang Li; Ning Li; Hengli Li; Jian Dou
Journal:  Med Sci Monit       Date:  2021-03-31

9.  Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Authors:  Xuqi Sun; Dandan Hu; Yaojun Zhang; Ning Lyu; Li Xu; Qifeng Chen; Jinfa Lai; Minshan Chen; Ming Zhao
Journal:  J Hepatocell Carcinoma       Date:  2020-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.